This study covers the Russian biopharmaceutical and biomedicine markets. Key segments for the biopharmaceutical market include cytokines, monoclonal antibodies, vaccines, and antibiotics. The biomedicine market includes regenerative medicine, nanomedicine, biocompatible medical materials, diagnostics, post-genomic technologies, and bioinformatics. This research shows the latest developments in Russian biotechnology, defines key segments and emerging leaders, and outlines government policies and support mechanisms. The base year for the study is 2013 with a forecast period of 2014 to 2018.